Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Shares Down 0.3% – Time to Sell?

Fidelity Disruptive Medicine ETF (NASDAQ:FMED)’s stock price traded down 0.3% on Monday . The stock traded as low as $25.94 and last traded at $26.00. 4,989 shares changed hands during trading, a decline of 35% from the average session volume of 7,634 shares. The stock had previously closed at $26.09.

Fidelity Disruptive Medicine ETF Trading Down 0.3%

The stock’s 50 day moving average is $26.92 and its 200-day moving average is $26.24. The company has a market cap of $59.80 million, a P/E ratio of 41.33 and a beta of 1.00.

Institutional Investors Weigh In On Fidelity Disruptive Medicine ETF

Several institutional investors and hedge funds have recently made changes to their positions in FMED. Glass Jacobson Investment Advisors llc lifted its position in Fidelity Disruptive Medicine ETF by 44.0% in the 4th quarter. Glass Jacobson Investment Advisors llc now owns 1,260 shares of the company’s stock valued at $34,000 after acquiring an additional 385 shares in the last quarter. Virtu Financial LLC bought a new position in shares of Fidelity Disruptive Medicine ETF during the fourth quarter valued at $228,000. Vise Technologies Inc. purchased a new stake in shares of Fidelity Disruptive Medicine ETF during the fourth quarter valued at $234,000. BXM Wealth LLC purchased a new stake in shares of Fidelity Disruptive Medicine ETF during the fourth quarter valued at $243,000. Finally, Jane Street Group LLC increased its holdings in Fidelity Disruptive Medicine ETF by 0.8% in the 1st quarter. Jane Street Group LLC now owns 66,382 shares of the company’s stock worth $1,567,000 after buying an additional 499 shares in the last quarter.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.